Clinical Utility of Genotyping (Webinar)

Dr. Michael Gold discusses the importance of HPV 16 and 18 in the etiology of cervical cancer, the evidence for risk stratification with HPV 16 and 18, and the guidelines supporting genotyping use in practice.

View the webinar below: